摘要
目的探讨更年期女性非前庭性眩晕的治疗方法和疗效。方法55例非前庭性眩晕患者为观察对象,其中只接受心理疏导治疗者为对照组(10例),同意心理疏导及药物治疗者为研究组(45例)。2组均接受心理疏导治疗,研究组另服健脑合剂,无效者加用甲磺酸倍他司汀口服4周疗程并分析疗效。结果对照组有效1例,占10.0%;研究组El服健脑合剂后,有效率为51.1%(23/45)。研究组无效患者中加用甲磺酸倍他司汀后,63.6%(14/22)患者得到有效控制。总体治疗有效率为82.2%(37/45),甲磺酸倍他司汀治疗前后比较差异有统计学意义(X2=9.800,P〈0.01)。结论心理疏导加健脑合剂可作为更年期女性非前庭性眩晕初次治疗的首选方案,倍他司汀可作为进一步治疗的选择。
Objective To investigate the methods and effect of treating non-vestibular vertigo in menopausal women. Methods Ten menopausal women with vertigo were treated by psychological consultation (PC) as control. 45 cases were treated by PC with Jiannao Heji ( JH), while the non-response cases were treated with betahistine mesy- late(BM). Results One case(10.0% ) was controlled by PC. Twenty-three cases(51.1% ) were controlled by PC with JH. Among non-response cases, 63.6% (14/22) were controlled by adding BM. Total control rate of this two- step treatment was 82.2%. The control rate was significantly improved by adding BM. Conclusion Psychological consultation with Jiannao Heji can be the first treatment of non-vestibular vertigo in menopausal women, while beta- histine mesylate can be the next choice.
出处
《中国医药》
2013年第9期1315-1316,共2页
China Medicine
基金
国家科技支撑计划项目(2012BA112802)
关键词
眩晕
围绝经期
治疗结果
Vertigo : Perimenopause : Treatment outcome